General Information of the Compound
| Compound ID |
CP0135565
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
AL-12959
Show/Hide
|
||||||||||||||||||
| Synonyms |
15(S)-HETE
15(S)-Hydroxyeicosatetraenoic acid
15(S)-hydroxyeicosatetraenoic acid (ophthalmic, dry eye), Alcon
PROCALYX
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H32O3
|
||||||||||||||||||
| Molecular Weight |
320.473
|
||||||||||||||||||
| Canonical SMILES |
CCCCC[C@H](O)\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H32O3/c1-2-3-13-16-19(21)17-14-11-9-7-5-4-6-8-10-12-15-18-20(22)23/h4-5,8-11,14,17,19,21H,2-3,6-7,12-13,15-16,18H2,1H3,(H,22,23)/b5-4-,10-8-,11-9-,17-14+/t19-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
JSFATNQSLKRBCI-VAEKSGALSA-N
|
||||||||||||||||||
| CAS |
54845-95-3
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound